Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$68.67 - $84.02 $961 - $1,176
-14 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$76.02 - $100.5 $152 - $201
-2 Reduced 12.5%
14 $1,000
Q4 2020

Feb 16, 2021

BUY
$80.74 - $97.7 $1,291 - $1,563
16 New
16 $1,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Standard Family Office LLC Portfolio

Follow Standard Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Standard Family Office LLC with notifications on news.